Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB known ✓ | P27338 | 2/20 | 0.46 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.46 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 2/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.55 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.55 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | METAP1 | P53582 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28675057 | 1.00 | ANPEP (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Hydrochloric Acid SCHEMBL20590185 | 1.00 | ANPEP (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| SCHEMBL194645 | 0.98 | ANPEP (0.57) | ANPEPERAP1ERAP2METAP2METAP1 | |
| SCHEMBL4282969 | 0.98 | ANPEP (0.57) | ANPEPERAP1ERAP2METAP2METAP1 | |
| SCHEMBL1760865 | 0.98 | ANPEP (0.57) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Sulfuric Acid SCHEMBL1605647 | 0.88 | BLM (0.55) | ANPEPERAP1ERAP2METAP2METAP1 | |
| Hydrochloric Acid SCHEMBL326014 | 0.87 | GRIK1 (0.53) | ANPEPERAP1ERAP2MAOBMAOA | |
| Nitric Acid SCHEMBL7055225 | 0.85 | ANPEP (0.50) | ANPEPERAP1ERAP2METAP2METAP1 | |
| SCHEMBL14544283 | 0.84 | GRIK1 (0.54) | ANPEPERAP1ERAP2MAOBMAOA | |
| SCHEMBL456442 | 0.84 | GRIK1 (0.54) | ANPEPERAP1ERAP2MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2873 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041777-A1 | PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS | RB HEALTH US LLC (US) | 2024-02-08 | — | — | US | claimed |
| US-20220079937-A1 | PHARMACEUTICAL FORMULATION | RB HEALTH (US) LLC | 2022-03-17 | — | — | US | claimed |
| CN-113861466-A | Winding film material and preparation method thereof | 宁波鸿雁包装材料有限公司 | 2021-12-31 | — | — | CN | claimed |
| CN-113425847-A | Tablet coating film, raw material composition and preparation thereof, controlled-release tablet and preparation thereof | 上海汉都医药科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| US-20200306176-A1 | OSMOTIC PUMP CONTROLLED RELEASE FORMULATIONS | AUSTARPHARMA LLC (US) | 2020-10-01 | — | — | US | claimed |
| US-20200261373-A1 | PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS | RECKITT BENCKISER LLC (US) | 2020-08-20 | — | — | US | claimed |
| US-10668012-B2 | Chewable sustained release formulations | FARNAM COMPANIES, INC. (US) | 2020-06-02 | — | — | US | claimed |
| CN-108061777-B | Method for detecting residual quantity of 34 illegally added medicines in weight-losing health-care food | 浙江公正检验中心有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-107675364-B | Method for preparing double-drug-loading composite fiber membrane by emulsion electrospinning technology | 天津工业大学 | 2020-04-24 | — | — | CN | claimed |
| CN-110857220-A | Method for mineralizing and depositing polymer carrying salt ions layer by layer | 中石化石油工程技术服务有限公司 | 2020-03-03 | — | — | CN | claimed |
| US-4883660-A | Gel bases for pharmaceutical compositions | THAMES PHARMACAL CO., INC. (US) | 1989-11-28 | — | — | US | claimed |
| US-4882158-A | CHEWABLE | WARNER LAMBERT CO. (US) | 1989-11-21 | — | — | US | claimed |
| EP-0132472-B1 | MEDICATED PRODUCTS CONTAINING A MAGNESIUM TRISILICATE ADSORBENT WITH A MEDICAMENT DRUG ADSORBED THEREON | WARNER-LAMBERT COMPANY (US) | 1989-06-21 | — | — | EP | claimed |
| US-4758424-A | Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation | WARNER-LAMBERT COMPANY (US) | 1988-07-19 | — | — | US | claimed |
| US-4753800-A | DRUGS ADSORBED ONTO MAGNESIUM ALUMINUM STEARATE | WARNER-LAMBERT COMPANY (US) | 1988-06-28 | — | — | US | claimed |
| EP-0219458-A2 | Medicament adsorbates and their preparation | WARNER-LAMBERT COMPANY (US) | 1987-04-22 | — | — | EP | claimed |
| US-4631284-A | SPRAY DRYING AN AQUEOUS SLURRY OF MIXTURE | MALLINCKRODT, INC. (US) | 1986-12-23 | — | — | US | claimed |
| US-4576645-A | Whipped gel composition | BLOCK DRUG CO., INC. (US) | 1986-03-18 | — | — | US | claimed |
| EP-0132472-A1 | Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon | WARNER-LAMBERT COMPANY (US) | 1985-02-13 | — | — | EP | claimed |
| US-4260596-A | Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same | BRISTOL-MYERS COMPANY (US) | 1981-04-07 | — | — | US | claimed |